3 in food and ingested drugs must reformulate their products by Jan. 15, 2027, according to the FDA's new guidance. Imported foods that contain the dye will also need to comply with US regulations.

Project Equity wasn’t the first time the agency sought to address inclusivity problems in clinical trials, but it helped lead to the development of formal guidance around “diversity action plans.” ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

These will immediately benefit from the free membership Breakdown and Recovery Scheme whilst the remainder of the vehicles will benefit by using the RTR national recovery and repair network, ensuring ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...

The initial orders were delivered Tuesday to staff at agencies inside the US Department of Health and Human Services, including to officials at the US Food and Drug Administration, the US Centers ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

The FDA still has not authorized any tools that continuously adapt or use generative AI. While the guidance documents should provide some clarity for medical device developers, questions still loom ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Emerging outbreaks, new discoveries, and noteworthy drug approvals are just some of the many things that agencies like the CDC and FDA regularly communicate to the general public and clinicians.

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...